Texas Capital Bancshares, Inc. Announces Quarterly Dividend for Preferred Stock

DALLAS, Jan. 30, 2017 (GLOBE NEWSWIRE) — Texas Capital Bancshares, Inc. (NASDAQ:TCBI), the parent company of Texas Capital Bank, and their board of directors declared a cash dividend of $0.40625 per share of the non-cumulative perpetual preferred stock, Series A, which is traded on the NASDAQ under the symbol “TCBIP”. The Series A Preferred Stock...
Read More →

Ocera Announces Top-line Results for Phase 2b Study in Hepatic Encephalopathy

//
Categories
Primary and Secondary Endpoints Showed Trend and Dose-Related Clinical Benefit Although Not Statistically Significant Ammonia Scavenger OCR-002 Demonstrated Statistically Significant Reduction in Ammonia Levels OCR-002 Was Safe and Well-Tolerated Management to Host Conference Call and Webcast Today at 8:30 a.m. ET PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., Jan. 30, 2017 (GLOBE NEWSWIRE) —...
Read More →

Ormat Technologies, Inc. to Host Conference Call Announcing Fourth Quarter and Year-End 2016 Financial Results on March 1, 2017

RENO, Nev., Jan. 30, 2017 (GLOBE NEWSWIRE) — Ormat Technologies, Inc. (NYSE:ORA) plans to announce its fourth quarter and year-end 2016 financial results in a press release that will be issued on Tuesday, February 28, 2017 after the market close. The Company has scheduled a conference call to discuss the results at 10 a.m. EST...
Read More →

Broadwind Energy Reaches Agreement to Acquire Red Wolf Company, LLC

CICERO, Ill., Jan. 30, 2017 (GLOBE NEWSWIRE) — Broadwind Energy, Inc. (NASDAQ:BWEN) today announced that it has reached agreement  to acquire Red Wolf Company, LLC, a privately-held fabricator, kitter and assembler of industrial systems primarily supporting the global gas turbine market.  The transaction, which is subject to the execution of definitive agreements, is expected to...
Read More →

PharmaCyte Biotech Retains Facet Life Sciences to Guide Pancreatic Cancer Therapy Development Lifecycle with FDA

//
Categories
LAGUNA HILLS, Calif., Jan. 30, 2017 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, officially announced today that PharmaCyte has retained Facet Life Sciences, Inc. (Facet) to guide PharmaCyte through its pancreatic cancer therapy development...
Read More →

Global LED Lighting Market will reach USD 54.28 Billion by 2022: Zion Market Research

Sarasota, FL, Jan. 30, 2017 (GLOBE NEWSWIRE) — Zion Market Research has published a new report titled “LED lighting Market for Residential, Architectural and Outdoor Applications: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2016 – 2022”. According to the report, the global LED lighting market accounted for USD 26.09 billion in 2016 and is expected to reach...
Read More →

Wheeler Real Estate Investment Trust, Inc. Pre-Announces Fourth Quarter 2016 Pro Forma Affo Run Rate, Highlights 2016 Accomplishments and Sets Fourth Quarter 2016 Earnings Release Date

Unaudited fourth quarter 2016 pro forma AFFO per share run rate of $0.21 on an annualized basis, in line with management’s guidance range of $0.21 and the company’s common dividend Completed the acquisition of twenty-three grocery-anchored shopping centers in 2016 for total aggregate purchase price of $186 million inclusive of nine properties totaling $115 million...
Read More →

FibroGen’s Roxadustat (FG-4592) Meets Primary Endpoints in Two Phase 3 Anemia Studies in China

//
Categories
SAN FRANCISCO, Jan. 30, 2017 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical company, and its subsidiary FibroGen China Medical Technology Development Co., Ltd. (FibroGen China), today reported positive topline results from the two Phase 3 clinical studies of roxadustat (FG-4592 or 罗沙司他[1]) designed to support new drug application submission in China.  Roxadustat is...
Read More →